Pillstats
Rx only · Tablet, Film Coated · Oral

Daridorexant

Brands: Quviviq · Daridorexant

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US2 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN05CJ03
RxCUI (US)2591497
US makers1 labelers
Packages4
DEA / ScheduleCIV

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$4.81$9.61$14.42$19.22Jan 2026Jun 2026Jul 2026
$16.710
Latest avg · Jul 22, 2026
-0%
Since Jan 1, 2026
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.2K6.5K9.7K13K2025 Q12025 Q22025 Q32025 Q42026 Q1
10K
Rx · 2026 Q1
298K
Units dispensed
-8%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Idorsia Pharmaceuticals Ltdunknown4SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.